However, treated mice exhibited reduced levels of keratinocyte chemoattractant, interleukin-10 (IL-10), and systemic interferon-gamma, indicating that E. purpurea may modulate cytokines to reduce the clinical symptoms of influenza [116]. This evidence concerns the gene IL10 and influenza.